Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells
Last reviewed: June 24, 2026 Last updated: June 24, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
According to a press release from Lilly (the maker of Foundayo), orforglipron will cost around $25 per month with commercial insurance and a drug savings card
Overall, ipamorelin is a promising peptide that may have several beneficial effects on the body
Blood sugar dysregulation reduces inner ear blood flow through endothelial dysfunction
GLP-1 Users Want Products to Meet Their Needs About one in three current users say they have come across products marketed specifically for GLP-1 users, and more than half of current users would be more likely to purchase some products if they catered specifically to those on GLP-1 medications